Lori McKenna Gorski
Director/Board Member at Our Odyssey, Inc.
Lori McKenna Gorski active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Our Odyssey, Inc. | Director/Board Member | - | - |
Career history of Lori McKenna Gorski
Former positions of Lori McKenna Gorski
| Companies | Position | Start | End |
|---|---|---|---|
| CYCLO THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Public Communications Contact | 08/03/2011 | - |
| RADIUS HEALTH, INC. | Public Communications Contact | - | - |
| THERMO FISHER SCIENTIFIC | Public Communications Contact | - | - |
Training of Lori McKenna Gorski
| Boston College | Undergraduate Degree |
Statistics
International
| United States | 7 |
Operational
| Public Communications Contact | 3 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| THERMO FISHER SCIENTIFIC | Health Technology |
| CYCLO THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
| Our Odyssey, Inc. |
- Stock Market
- Insiders
- Lori McKenna Gorski
- Experience
